In the pivotal clinical trial, the safety and efficacy of desloratadine were evaluated in more than 2,300 patients aged 12 to 75 years with seasonal allergic rhinitis. The agent significantly ...

The potency, slow dissociation rate, and noncompetitive binding of desloratadine were predictive of its antihistaminic activity and long duration of action. The ability of desloratadine to inhibit ...